Evangelia Vlachou, MD

Evangelia Vlachou, MD, a postdoctoral research fellow at Johns Hopkins Medicine.

Articles by Evangelia Vlachou, MD

Screenshot of an interview with Evangelia Vlachou, MD

Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer

February 14th 2025

Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.

Evangelia Vlachou, MD

Articles by Evangelia Vlachou, MD

Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer

Latest Updated Articles

Trending on AJMC

5 FAQs: Ebola Outbreaks and the Challenge of Public Trust

Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox

How Hospital Specialty Pharmacies Are Closing the Pharmacy Desert Gap

How Healthy Gut Microbiota Can Give CAR T-Cell Recipients a Leg Up

Patients on GLP-1s Increasingly Carry Diagnoses for New Indications